|
|
||||||||||
Published Online, March 3, 2009. www.theannals.com, DOI 10.1345/aph.1L504a
Also, in Table 1, under the Cost/LYG column of reference 23, the last 2 lines should be deleted.
Footnotes
Letters are subject to review prior to acceptance. They should address areas related to pharmacy practice, research, or education, or articles recently published. Corrections of previously published material also are accepted. Letters are limited to no more than five authors. In cases where adverse effects or drug interactions are described, the Naranjo ADR probability scale (Clin Pharmacol Ther 1981;30:239-45) or DIPS scale (Ann Pharmacother 2007;41:674-80. DOI 10.1345/aph.1H423), respectively, should be used to determine the likelihood that the adverse effect or interaction was drug-related.
| ||||||||||||||||||||||||||||||||||||||||||||